PharmaNutra U.S.A. Corp.
PharmaNutra U.S.A. Corp. is the Group’s foreign subsidiary based in the United States. Founded in 2022, it was established to expand the company’s presence in one of the most competitive and dynamic markets in the world. The subsidiary is responsible for promoting and distributing the Group’s products, with a particular focus on the SiderAL®, ApportAL® and Cetilar® brands, all of which are already recognised for their quality and innovation. PharmaNutra U.S.A. plays a crucial role in enhancing the brand’s visibility and capitalising on opportunities in the North American market, with a marketing strategy that integrates online platforms and direct distribution across the country’s key sales channels.
Find out more
PharmaNutra España
PharmaNutra España is the Group’s subsidiary dedicated to the Iberian market. Its mission is to strengthen PharmaNutra’s presence in Spain and neighbouring countries by offering top-tier nutraceutical and pharmaceutical solutions, with an emphasis on the Cetilar® and Cetilar® Nutrition brands.
Thanks to a highly skilled local team and a targeted commercial strategy, PharmaNutra España has become a trusted partner for doctors, pharmacists and distributors in the region.
Akern S.r.l.
Acquired by the Group in 2022, Akern S.r.l. is a leading company in the field of bioelectrical impedance and body composition analysis. For over 40 years, Akern has developed cutting-edge medical software and diagnostic devices used in clinical, sports and nutritional fields, becoming a recognised leader in Europe for body composition science using bioelectrical impedance techniques.
The company’s mission is to support doctors and researchers in the fight against chronic degenerative diseases by providing clinically relevant results that assist with in diagnosis and therapeutic decision-making.
Akern’s scientific and technological expertise in the nutritional field adds significant value to the Group, expanding its portfolio of innovative products and enriching its research and development initiatives.
Find out more
Athletica Cetilar S.r.l.
Athletica Cetilar S.r.l. is the Group’s company dedicated to promoting and developing sports-related projects. Established in 2024 in collaboration with Athletica S.n.c., which holds 30% of the shares, Athletica Cetilar is a cutting-edge sports medicine, physiotherapy, rehabilitation and athletic training centre designed to enhance the performance of professional athletes.
The centre’s mission is to redefine physical and mental well-being for athletes by integrating advanced technologies with top-tier specialists in the field. Through strategic partnerships and sponsorships with athletes, teams and sporting events, the company elevates the Cetilar® brand and strengthens the connection between the Group’s products and athletic performance.
Athletica Cetilar embodies the dynamic and ambitious spirit of the Group, fostering unique connections between nutraceuticals, innovation and sport.
Find out more